2008
DOI: 10.1038/embor.2008.90
|View full text |Cite
|
Sign up to set email alerts
|

The nature and character of the transition state for the ADP‐ribosyltransferase reaction

Abstract: Exotoxin A (ExoA) from Pseudomonas aeruginosa is an important virulence factor that belongs to a class of exotoxins that are secreted by pathogenic bacteria which cause human diseases such as cholera, diphtheria, pneumonia and whooping cough. We present the first crystal structures, to our knowledge, of ExoA in complex with elongation factor 2 (eEF2) and intact NAD þ , which indicate a direct role of two active-site loops in ExoA during the catalytic cycle. One loop moves to form a solvent cover for the active… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
99
0
4

Year Published

2010
2010
2015
2015

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 82 publications
(106 citation statements)
references
References 26 publications
(33 reference statements)
2
99
0
4
Order By: Relevance
“…3, e and f), wild type full-length toxin apparently has some activity, although at levels more than 15-fold lower than the corresponding catalytic fragment, cholix c . Activity was virtually abolished for the E581A and E574A/E581A mutants (29,300-and 12,600-fold, respectively), in part due to weaker NAD ϩ substrate binding, impaired productive substrate binding, and an inability to stabilize the transition state complex (11,14). Activity in these mutants is so low that accurate measurements are challenging.…”
Section: Cholixmentioning
confidence: 99%
See 2 more Smart Citations
“…3, e and f), wild type full-length toxin apparently has some activity, although at levels more than 15-fold lower than the corresponding catalytic fragment, cholix c . Activity was virtually abolished for the E581A and E574A/E581A mutants (29,300-and 12,600-fold, respectively), in part due to weaker NAD ϩ substrate binding, impaired productive substrate binding, and an inability to stabilize the transition state complex (11,14). Activity in these mutants is so low that accurate measurements are challenging.…”
Section: Cholixmentioning
confidence: 99%
“…A proposed overall cholix-NAD ϩ -eEF2 Michaelis complex is shown in Fig. 2c based on our previous x-ray structure of ExoA with eEF2 and NAD ϩ (13,14). A close-up of the cholix-NAD ϩ -eEF2 interface within the proposed complex is shown in Fig.…”
Section: Cholix-nadmentioning
confidence: 99%
See 1 more Smart Citation
“…Although these new recombinant immunotoxins have shown high potency in killing tumour cells with high specificity, they too share the limitation of targeting a single cellular substrate, eEF-2 (Jørgensen et al, 2008). In fact, mutations in eEF-2 have been shown to emerge easily, conferring resistance to these toxins in cancer cells (Foley et al, 1995;Jørgensen et al, 2008;Wei et al, 2012). & Barbieri, 2003;Garrity-Ryan et al, 2004), which play important roles in survival, proliferation, metastasis and angiogenesis in cancer.…”
Section: Introductionmentioning
confidence: 99%
“…For example, Pseudomonas exotoxin A and diphtheria toxin are the most common bacterial toxins that have been or are currently under clinical evaluation against a variety of haematologic malignancies and solid tumours with promising results (reviewed by Becker & Benhar, 2012). Although these new recombinant immunotoxins have shown high potency in killing tumour cells with high specificity, they too share the limitation of targeting a single cellular substrate, eEF-2 (Jørgensen et al, 2008). In fact, mutations in eEF-2 have been shown to emerge easily, conferring resistance to these toxins in cancer cells (Foley et al, 1995;Jørgensen et al, 2008;Wei et al, 2012).…”
Section: Introductionmentioning
confidence: 99%